Literature DB >> 17060099

Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction.

Jochen Wöhrle1, Thorsten Nusser, Nico Merkle, Hans A Kestler, Olaf C Grebe, Nikolaus Marx, Martin Höher, Matthias Kochs, Vinzenz Hombach.   

Abstract

The present study examined the association of myocardial perfusion reserve index (MPRI) in cardiovascular magnetic resonance (CMR) with coronary microvascular dysfunction (CMD) and serum levels of markers of inflammation or endothelial activation. Twelve patients with typical angina pectoris without coronary artery disease were enrolled in this study, and CMR perfusion was analyzed using a steady-state-free-precession sequence with 3 short axis slices per heartbeat during first pass of 0.025 mmol Gadolinium-DTPA/kg body weight. The upslope of myocardial signal intensity curves was used to calculate MPRI. CMD was assessed by intracoronary Doppler flow measurement and biplane angiography. Both MPRI and CMD were assessed during endothelium-independent stimulation with intravenous adenosine and during endothelium-dependent stimulation with intracoronary infusion of acetylcholine. Serum values of soluble CD40 ligand (sCD40L), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble intercellular adhesion molecule-1 (sICAM-1), and C-reactive protein (CRP) were measured. Impaired MPRI correlated significantly with a decrease in coronary blood flow reserve after both endothelium-dependent (p = 0.033) and endothelium-independent (p = 0.022) stimulation. Serum levels above the median of all normal ranged biomarkers sCD40L, TNF-alpha, IL-6, sICAM-1 and CRP were associated with an impaired MPRI for stimulation with adenosine as well as acetylcholine. In multivariable analyses, sCD40L (p < 0.001) and TNF-alpha (p = 0.011) were significantly associated with a decrease in MPRI on adenosine, as were TNF-alpha (p = 0.016) and sICAM-1 (p = 0.022) for a decrease in MPRI on acetylcholine. MPRI on adenosine significantly correlated with MPRI on acetylcholine (p < 0.001). Therefore, the present study demonstrates safety and feasibility of an intracoronary infusion of acetylcholine during CMR perfusion analysis, thus allowing direct assessment of endothelial dependent vasomotor function at the myocardial level by CMR. Furthermore, we show that an impaired myocardial perfusion reserved in CMR is associated with established biomarkers of early atherosclerosis and significantly correlated with CMD. CMR combined with adenosine could be proposed as a non-invasive tool to evaluate CMD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060099     DOI: 10.1080/10976640600737649

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  20 in total

1.  Coronary vasomotor responses to isometric handgrip exercise are primarily mediated by nitric oxide: a noninvasive MRI test of coronary endothelial function.

Authors:  Allison G Hays; Micaela Iantorno; Sahar Soleimanifard; Angela Steinberg; Michael Schär; Gary Gerstenblith; Matthias Stuber; Robert G Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-27       Impact factor: 4.733

2.  Current Diagnostic and Therapeutic Strategies in Microvascular Angina.

Authors:  Bryn Mumma; Nathalie Flacke
Journal:  Curr Emerg Hosp Med Rep       Date:  2015-03

3.  Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls.

Authors:  Chrisandra L Shufelt; Louise E J Thomson; Pavel Goykhman; Megha Agarwal; Puja K Mehta; Tara Sedlak; Ning Li; Edward Gill; Bruce Samuels; Babak Azabal; Saibal Kar; Kamlesh Kothawade; Margo Minissian; Piotr Slomka; Daniel S Berman; C Noel Bairey Merz
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

4.  Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.

Authors:  Akhil Narang; John E Blair; Mita B Patel; Victor Mor-Avi; Savitri E Fedson; Nir Uriel; Roberto M Lang; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-04       Impact factor: 2.357

5.  Assessment of myocardial perfusion for detection of coronary artery stenoses by steady-state, free-precession magnetic resonance first-pass imaging.

Authors:  Nico Merkle; Jochen Wöhrle; Olaf Grebe; Thorsten Nusser; Markus Kunze; Hans A Kestler; Matthias Kochs; Vinzenz Hombach
Journal:  Heart       Date:  2007-05-08       Impact factor: 5.994

Review 6.  Evaluation of the microcirculation: advances in cardiac magnetic resonance perfusion imaging.

Authors:  Amit R Patel; Frederick H Epstein; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

7.  Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score.

Authors:  Ronen Rubinshtein; Eric H Yang; Charanjit S Rihal; Abhiram Prasad; Ryan J Lennon; Patricia J Best; Lilach O Lerman; Amir Lerman
Journal:  Eur Heart J       Date:  2009-11-05       Impact factor: 29.983

8.  Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease.

Authors:  Jochen Wöhrle; Nikolaus Marx; Wolfgang Koenig; Vinzenz Hombach; Hans A Kestler; Martin Höher; Thorsten Nusser
Journal:  Clin Res Cardiol       Date:  2008-04-24       Impact factor: 5.460

9.  CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation.

Authors:  Karen Y Stokes; Leshanna Calahan; Candiss M Hamric; Janice M Russell; D Neil Granger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-26       Impact factor: 4.733

10.  Quantitative 3D myocardial perfusion with an efficient arterial input function.

Authors:  Jason Kraig Mendes; Ganesh Adluru; Devavrat Likhite; Merlin J Fair; Peter D Gatehouse; Ye Tian; Apoorva Pedgaonkar; Brent Wilson; Edward V R DiBella
Journal:  Magn Reson Med       Date:  2019-10-31       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.